GENEVA, July 27 -- RINUAGENE BIOTECHNOLOGY CO., LTD. filed a patent application (CN2025/073829) for “HUMAN PAPILLOMA VIRUS (HPV) MRNA VACCINES AND USES THEREOF”. With publication no. WO/2025/162105, here are the other details related to the patent application:
Kind: Corrected version of pamphlet [A9]
IPC: A61K 39/12
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....